Monday, September 28, 2026
- Advertisement -spot_img

TAG

Restructuring

CSL Reports $2.6B Loss Amid Restructuring, Flu Vaccine Rates Drop

CSL slams a 184% plunge in net profit, wiping out earnings as restructuring costs and weak flu vaccine demand hit the bottom line. The...

Latest news

- Advertisement -spot_img